在有效的骨癌治疗中,半孔生物活性眼镜的进步:最近的发展和未来的前景
Laila Hussein1, Mona Moaness1, Mostafa Mabrouk1
1Refractories, Ceramics and Building Materials Department, Advanced Materials, Technology and Mineral Resources Research Institute, National Research Centre, 33 El Bohouth St., Dokki, PO Box 12622, Cairo, Egypt.
Biomaterials and biosystems
|March 14, 2025
概括
半孔生物活性眼镜 (MBG) 在治疗骨癌,包括骨肉瘤 (OS) 方面表现有前途. 这些材料充当药物输送系统和支架,改善骨愈合,并可能取代传统疗法.
科学领域:
- 生物材料科学 生物材料科学
- 在瘤学瘤学.
- 再生医学是一种再生医学.
背景情况:
- 骨癌,特别是骨肉瘤 (OS),由于患病率和死亡率高,因此存在重大治疗挑战.
- 像手术,放射和化疗等传统治疗方法都有局限性,通常无法完全根除瘤,导致关键大小的骨缺陷.
- 新兴疗法在有效地向癌细胞而不损害健康组织方面面临挑战.
研究的目的:
- 审查用于骨癌治疗的半孔生物活性眼镜 (MBG) 应用的最新进展,特别关注骨肉瘤 (OS).
- 探索MBG作为多功能药物输送系统 (DDS) 和用于增强骨愈合和恢复的支架的潜力.
- 为了解各种MBG类型及其未来骨癌治疗的发展提供见解,与骨病治疗中的现有生物活性眼镜 (BG) 一起.
主要方法:
- 在过去十年中报告的半孔生物活性眼镜 (MBG) 的文献综述.
- 分析MBG作为药物输送系统 (DDS) 和骨组织工程的支架的特性.
- 检查MBG在骨髓瘤 (OS) 治疗中的当前和潜在应用.
主要成果:
- 半孔生物活性眼镜 (MBG) 证明了作为药物输送系统 (DDS) 的多功能能力.
- 可以将MBG设计成支架,以促进治疗剂和生长因子的局部输送.
- 这些支架促进有效的骨愈合和恢复,为传统治疗提供了一个有希望的替代方案.
结论:
- 半孔生物活性眼镜 (MBG) 是对骨癌,特别是骨肉瘤 (OS) 的有前途的治疗策略.
- MBG作为DDS和骨再生支架的能力提高了治疗效率和局部骨修复.
- 对MBG开发和应用的进一步研究具有显著的潜力,可以改善骨癌患者的治疗结果.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


